Search

everythinglearnresearchcommunity

for

Search:↓

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Purple corn extract may help reduce prostate enlargement and inflammation.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Herbal remedies like ginseng and green tea may help regenerate hair follicles damaged by pesticides.

Post-orchidectomy semen has better DNA integrity for fertility treatments.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Early diagnosis and surgery are crucial for managing cryptorchidism and related hair loss in dogs.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Finasteride may improve prostate cancer treatment outcomes.